跳至主要内容
临床试验/NCT01270152
NCT01270152已完成2 期

Determining the Safe Dosage of Ascorbic Acid Used in the Treatment of Occluded Totally Implanted Central Venous Catheter.

University of Sao Paulo1 个研究点 分布在 1 个国家目标入组 21 人开始时间: 2008年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
21
试验地点
1
主要终点
Restore patency

研究概览

简要总结

The hypothesis of the study is to evaluate whether ascorbic acid is able to clear totally implanted central venous catheter

详细描述

Totally implanted catheter is often occluded and thrombolytic drugs are usually used to restore permeability. In Brazil, the ascorbic acid has been used successfully by a service specialist in cancer treatment. However, no literature on international research that evaluates the efficacy and safety of this procedure. That was why it was decided to develop this research.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of partial or complete obstruction of the totally implanted central venous catheter;
  • No signs of inflammation in the area of the port.

排除标准

  • Use of oral anticoagulants or intravenous administration in the last seven days;
  • Diagnostic and / or suspected infection in the totally implanted central venous catheter;
  • Rupture, displacement or fissure of the totally implanted central venous catheter;
  • Presence of thrombosis in the vein where the catheter is inserted.

研究组 & 干预措施

group 50 mg ascorbic acid

Experimental

this arm received a dose of 50 mg of ascorbic acid administered inside the catheter and maintained for up to 60 minutes

干预措施: Ascorbic Acid (Drug)

group 100mg ascorbic acid

Experimental

this arm received a dose of 100 mg of ascorbic acid administered inside the catheter and maintained for up to 60 minutes

干预措施: Ascorbic Acid (Drug)

group 200mg ascorbic acid

Experimental

this arm received a dose of 200 mg of ascorbic acid administered inside the catheter and maintained for up to 60 minutes

干预措施: Ascorbic Acid (Drug)

结局指标

主要结局

Restore patency

时间窗: 60 minutes after administration of ascorbic acid

the ascorbic acid is administered and remains inside the catheter within 60 minutes. The recovery of permeability is checked every 15 minutes until the maximum of 60 minutes

次要结局

  • Eosinophil count(within 24 hours)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验